CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Pulmonary artery denervation for treatment of a patient with pulmonary hypertension secondary to left heart disease 5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical Trial The contribution of tissue-grouped BMI-associated gene sets to cardiometabolic-disease risk: a Mendelian randomization study Ticagrelor versus clopidogrel in patients with acute coronary syndromes Assessment and Quantitation of Stent Results by Intracoronary Optical Coherence Tomography Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries A Prospective, Multicenter, Randomized, Open-label Trial to Compare Efficacy and Safety of Clopidogrel vs. Ticagrelor in Stabilized Patients with Acute Myocardial Infarction after Percutan eous Coronary Intervention: rationale and design of the TALOS-AMI trial EXCELling in Left Main Intervention Higher neutrophil-to-lymphocyte ratio (NLR) increases the risk of suboptimal platelet inhibition and major cardiovascular ischemic events among ACS patients receiving dual antiplatelet therapy with ticagrelor

Original Research2020 Dec 28;13(24):2825-2836.

JOURNAL:JACC Cardiovasc Interv. Article Link

Long-Term Outcomes After PCI or CABG for Left Main Coronary Artery Disease According to Lesion Location

J Hyun, J H Kim, MAIN-COMPARE Registry. Keywords: LMCAD; cardiovascular events; CABG vs. PCI; mortality

Full Text PDF